Maury Raycroft
Stock Analyst at Jefferies
(1.60)
# 3,425
Out of 5,182 analysts
59
Total ratings
35.56%
Success rate
-2.2%
Average return
Main Sectors:
Stocks Rated by Maury Raycroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYRA Tyra Biosciences | Maintains: Buy | $32 → $43 | $35.06 | +22.65% | 4 | Feb 3, 2026 | |
| DNTH Dianthus Therapeutics | Maintains: Buy | $66 → $81 | $83.67 | -3.19% | 3 | Feb 2, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $114 → $63 | $24.53 | +156.83% | 1 | Dec 30, 2025 | |
| MREO Mereo BioPharma Group | Downgrades: Hold | $7 → $0.5 | $0.28 | +79.66% | 2 | Dec 30, 2025 | |
| CELC Celcuity | Maintains: Buy | $108 → $134 | $120.07 | +11.60% | 2 | Dec 2, 2025 | |
| AUPH Aurinia Pharmaceuticals | Upgrades: Buy | $10 → $21 | $16.04 | +30.92% | 1 | Nov 7, 2025 | |
| OPK OPKO Health | Downgrades: Hold | $2 → $1.6 | $1.21 | +32.23% | 1 | Oct 31, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $550 → $549 | $302.11 | +81.72% | 4 | Oct 30, 2025 | |
| KZR Kezar Life Sciences | Downgrades: Hold | $18 → $7 | $7.31 | -4.24% | 2 | Oct 17, 2025 | |
| KOD Kodiak Sciences | Initiates: Buy | $15 | $45.43 | -66.98% | 1 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $3.5 | $1.68 | +108.33% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $53 | $9.82 | +439.71% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $1.84 | +334.78% | 2 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $3 | $0.20 | +1,392.54% | 1 | Dec 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $9.90 | -39.39% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $25.14 | -24.42% | 1 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $23 → $15 | $3.69 | +306.50% | 1 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $180 | $12.46 | +1,345.20% | 1 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $23 | $1.44 | +1,497.22% | 1 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $195 | $1.69 | +11,438.46% | 1 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $11 | $8.86 | +24.15% | 8 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $32 → $6 | $37.11 | -83.83% | 2 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $92 → $75 | $70.13 | +6.94% | 5 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $3.07 | +258.31% | 1 | Sep 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $38 → $5 | $1.53 | +226.80% | 2 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $5.53 | +550.99% | 1 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $105 | $7.45 | +1,309.40% | 1 | May 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $172 | $52.06 | +230.39% | 2 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $2.70 | +1,640.74% | 1 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $42 | $13.20 | +218.18% | 3 | Nov 1, 2017 |
Tyra Biosciences
Feb 3, 2026
Maintains: Buy
Price Target: $32 → $43
Current: $35.06
Upside: +22.65%
Dianthus Therapeutics
Feb 2, 2026
Maintains: Buy
Price Target: $66 → $81
Current: $83.67
Upside: -3.19%
Ultragenyx Pharmaceutical
Dec 30, 2025
Maintains: Buy
Price Target: $114 → $63
Current: $24.53
Upside: +156.83%
Mereo BioPharma Group
Dec 30, 2025
Downgrades: Hold
Price Target: $7 → $0.5
Current: $0.28
Upside: +79.66%
Celcuity
Dec 2, 2025
Maintains: Buy
Price Target: $108 → $134
Current: $120.07
Upside: +11.60%
Aurinia Pharmaceuticals
Nov 7, 2025
Upgrades: Buy
Price Target: $10 → $21
Current: $16.04
Upside: +30.92%
OPKO Health
Oct 31, 2025
Downgrades: Hold
Price Target: $2 → $1.6
Current: $1.21
Upside: +32.23%
Alnylam Pharmaceuticals
Oct 30, 2025
Maintains: Buy
Price Target: $550 → $549
Current: $302.11
Upside: +81.72%
Kezar Life Sciences
Oct 17, 2025
Downgrades: Hold
Price Target: $18 → $7
Current: $7.31
Upside: -4.24%
Kodiak Sciences
Sep 22, 2025
Initiates: Buy
Price Target: $15
Current: $45.43
Upside: -66.98%
Jun 24, 2025
Initiates: Hold
Price Target: $3.5
Current: $1.68
Upside: +108.33%
Mar 11, 2025
Maintains: Buy
Price Target: $70 → $53
Current: $9.82
Upside: +439.71%
Feb 10, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $1.84
Upside: +334.78%
Dec 31, 2024
Maintains: Buy
Price Target: $7 → $3
Current: $0.20
Upside: +1,392.54%
Nov 18, 2024
Initiates: Buy
Price Target: $6
Current: $9.90
Upside: -39.39%
Jul 17, 2024
Initiates: Buy
Price Target: $19
Current: $25.14
Upside: -24.42%
May 7, 2024
Assumes: Buy
Price Target: $23 → $15
Current: $3.69
Upside: +306.50%
Mar 13, 2024
Initiates: Buy
Price Target: $180
Current: $12.46
Upside: +1,345.20%
Mar 5, 2024
Initiates: Buy
Price Target: $23
Current: $1.44
Upside: +1,497.22%
Feb 8, 2024
Initiates: Buy
Price Target: $195
Current: $1.69
Upside: +11,438.46%
Aug 4, 2023
Upgrades: Buy
Price Target: $11
Current: $8.86
Upside: +24.15%
Jan 4, 2023
Downgrades: Hold
Price Target: $32 → $6
Current: $37.11
Upside: -83.83%
Nov 29, 2022
Maintains: Buy
Price Target: $92 → $75
Current: $70.13
Upside: +6.94%
Sep 12, 2022
Initiates: Buy
Price Target: $11
Current: $3.07
Upside: +258.31%
Dec 2, 2021
Downgrades: Hold
Price Target: $38 → $5
Current: $1.53
Upside: +226.80%
Jun 1, 2021
Initiates: Buy
Price Target: $36
Current: $5.53
Upside: +550.99%
May 27, 2021
Initiates: Buy
Price Target: $105
Current: $7.45
Upside: +1,309.40%
Apr 21, 2021
Upgrades: Buy
Price Target: $172
Current: $52.06
Upside: +230.39%
Feb 24, 2020
Initiates: Buy
Price Target: $47
Current: $2.70
Upside: +1,640.74%
Nov 1, 2017
Maintains: Buy
Price Target: $36 → $42
Current: $13.20
Upside: +218.18%